Article Versions Notes

Egea J, Salleron J, Gourgou S, Ayav A, Laurent V, Juzyna B, Harlé A, Conroy T, Lambert A. Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial. Cancers. 2022; 14(20):5068. https://doi.org/10.3390/cancers14205068

Egea, Julie, Julia Salleron, Sophie Gourgou, Ahmet Ayav, Valérie Laurent, Béata Juzyna, Alexandre Harlé, Thierry Conroy, and Aurélien Lambert. 2022. "Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial" Cancers 14, no. 20: 5068. https://doi.org/10.3390/cancers14205068

Egea, J., Salleron, J., Gourgou, S., Ayav, A., Laurent, V., Juzyna, B., Harlé, A., Conroy, T., & Lambert, A. (2022). Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial. Cancers, 14(20), 5068. https://doi.org/10.3390/cancers14205068